What does CUSIP 87164F105 represent in this 13F holders report?

CUSIP 87164F105 is the security identifier for SNDX - Syndax Pharmaceuticals Inc - Common Stock used to aggregate holder disclosures.

How many institutions held SNDX - Syndax Pharmaceuticals Inc - Common Stock in Q1 2016?

27 institutional investors reported SNDX - Syndax Pharmaceuticals Inc - Common Stock for Q1 2016. Use the holders table for investor-level position and value details.

Syndax Pharmaceuticals Inc - Common Stock (SNDX)

CUSIP: 87164F105

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock
Shares outstanding: 86,727,396
Total 13F shares: 9,443,951
Share change: +9,443,951
Total reported value: $125,631,000
Price per share: $13.32
Number of holders: 27
Value change: +$125,631,000
Number of buys: 27

Quarterly Holders Quick Answers

What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016

Recent filing periods for CUSIP 87164F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q1 2016

As of 31 Mar 2016, Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,443,951 shares. The largest 10 holders included MPM ASSET MANAGEMENT LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, EcoR1 Capital, LLC, JENNISON ASSOCIATES LLC, BLACKROCK ADVISORS LLC, TIVERTON ASSET MANAGEMENT LLC, Redmile Group, LLC, and Boxer Capital, LLC. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2025 Across Filers

Q4 2025 holders

226

Q1 2016 holders

Holder diff

-199

Investor	Q4 2025 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.